07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

InKine management update

InKine Pharmaceutical Co. Inc. (INKP), New York, N.Y.   Business: Cancer, Autoimmune/inflammation   Transitions: Leonard Jacob named chairman and CEO, formerly president and CEO of Sangen Pharmaceutical Co., upon Sangen's acquisition by Panax Pharmaceutical Co....
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Panax board of directors update

Panax Pharmaceutical Co. Ltd. (PANX), New York, N.Y.   Business: Cancer   Retired: Armen Takhtajan, Ph.D., Chairman; retired   Resigned: Norman Eisner, director, while remaining CFO and Secretary of Panax   Resigned: David Zaretsky, director...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Panax Pharmaceutical Ltd., Sangen Pharmaceutical Co. deal

PANX and privately held Sangen will merge contingent upon the raising of $10-$15 million in a private direct offering. PANX's lead product is a tablet for clearing the colon prior to colonoscopy. PANX said the...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

InKine scientific advisory board update

InKine Pharmaceutical Co. Inc. (INKP), New York, N.Y.   Business: Cancer, Autoimmune/Inflammation   Appointed: Alan Schreiber, professor of medicine and assistant dean for research at the University of Pennsylvania School of Medicine, as chairman;George Tuszynski,...
08:00 , Jan 22, 2007 |  BC Week In Review  |  Company News

Antares board of directors update

Antares Pharma Inc. (AIS), Ewing, N.J.   Business: Drug delivery   Appointed: Leonard Jacob, former chairman and CEO of InKine Pharmaceutical Co. Inc.  ...
08:00 , Jan 15, 2007 |  BC Week In Review  |  Company News

Bradley board of directors update

Bradley Pharmaceuticals Inc. (BDY), Fairfield, N.J.   Business: Dermatology, Gastrointestinal   Appointed: Leonard Jacob, former CEO of InKine Pharmaceuticals Co. Inc., as chairman; he replaces Daniel Glassman, who will remain president and CEO  ...
08:00 , Mar 20, 2006 |  BC Week In Review  |  Clinical News

OsmoPrep regulatory update

FDA approved an NDA for OsmoPrep to cleanse the bowel prior to colonoscopy. The second-generation sodium phosphate purgative was received through the 2005 acquisition of InKine Pharmaceutical. SLXP also markets Visicol , a first-generation purgative,...
02:37 , Mar 18, 2006 |  BC Extra  |  Company News

FDA approves Salix's OsmoPrep

FDA approved OsmoPrep sodium phosphate tablets from Salix (SLXP) to cleanse the bowel prior to colonoscopy. SLXP gained the second-generation sodium phosphate purgative (formerly INKP-102 ) through its acquisition of InKine last year. SLXP also...
08:00 , Mar 13, 2006 |  BC Week In Review  |  Company News

PolyMedix management update

PolyMedix Inc. , Philadelphia, Penn.   Business: Infectious   Hired: Edward Smith as VP of finance and CFO, formerly executive director of finance at InKine Pharmaceutical Co. Inc.  ...
08:00 , Feb 13, 2006 |  BC Week In Review  |  Company News

Antares management update

Antares Pharma Inc. (AIS), Exton, Penn.   Business: Drug delivery   Hired: Robert Apple as SVP and CFO, formerly COO and CFO of InKine Pharmaceutical Co. Inc.   Retired: Lawrence Christian as VP of finance...